Moleculin Biotech Inc.

NASDAQ: MBRX · Real-Time Price · USD
0.67
0.02 (3.43%)
At close: Aug 15, 2025, 3:59 PM
0.67
-0.60%
After-hours: Aug 15, 2025, 06:40 PM EDT

Moleculin Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
126K 127K 222K 260K
Gross Profit
-126K -127K -222K -260K
Operating Income
-26.64M -29.63M -30.64M -22.97M
Interest Income
550K 1.37M 240K 306K
Pretax Income
-21.76M -29.77M -29.02M -15.89M
Net Income
-21.76M -29.77M -29.02M -15.89M
Selling & General & Admin
8.79M 10.02M 11.67M 8.39M
Research & Development
17.73M 19.49M 18.97M 14.42M
Other Expenses
126K 127K n/a 164K
Operating Expenses
26.64M 29.63M 30.64M 22.97M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
26.64M 29.63M 30.64M 22.97M
Income Tax Expense
n/a n/a -1.61M -7.03M
Shares Outstanding (Basic)
3.44M 1.98M 1.91M 1.79M
Shares Outstanding (Diluted)
3.44M 1.98M 1.91M 1.79M
EPS (Basic)
-6.32 -15.07 -15.22 -8.87
EPS (Diluted)
-6.32 -15.07 -15.22 -8.87
EBITDA
-21.64M -29.5M -30.51M -22.8M
EBIT
-21.76M -29.63M -30.64M -22.97M
Depreciation & Amortization
126K 127K 222K 260K